Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check2 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0; the study record still shows a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record. This prevents users from accessing the trial's details, including its title, design, eligibility criteria, locations, and contact information.SummaryDifference18%

- Check23 days agoChange DetectedRevision tag updated to v3.7.0, indicating a backend update to the page. The study content and displayed information remain unchanged.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a version bump for the page or site template. This change appears to reflect internal fixes or minor UI adjustments rather than edits to study data or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe Other Study ID Numbers now includes '2018 ( U.S. NIH Grant/Contract )', indicating the NIH funding source for the study.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision indicator updated from v3.6.4 to v3.6.5, indicating a platform-level update. This change does not modify study content or visible functionality.SummaryDifference0.0%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.